The Italian investment fund Mandarin Capital Partners II - MCP II, along with other major investors including Graziano Verdi at the helm of ItalCer, has announced the acquisition of La Fabbrica SpA, a high-end ceramic tile manufacturer based in the northern Italian town of Castel Bolognese.

Following the option to purchase Tagina announced by Graziano Verdi in the first few months of the year, this acquisition marks a further step forward in MCP II and ItalCer’s project to establish an Italian ceramic hub with the aim of “developing the markets that are most sensitive to the style and quality of Italian ceramics”.

Graziano Verdi also announced that construction will soon commence on a 4.0 factory in Tennessee, USA, with start-up planned by the end of 2018. “We want to develop a project in the high end of the market that will enable us to achieve good results abroad and strong growth,” commented VerdiWhile his goal is to “reach a turnover of 300 million euros within five years”, this figure may in fact be much higher depending on the external growth opportunities that arise.

Commenting on the acquisition of La Fabbrica, Verdi said: “La Fabbrica already produces high-end products in its facilities, whereas large-size panels are produced under licence by one of the top manufacturers in the segment, as is the case in the world of fashion.” He continued: “The brand is a world leader and in recent years has seen above-average growth rates in a sector that itself is growing much more rapidly than Italian and European industry as a whole.”

The goal is to support the international growth of the Company, leveraging Mipharm as a growth platform in the CDMO industry
Milan, 06th December 2016 - Mandarin Capital Partners II (MCP II)  has successfully acquired a majority stake in the share capital of Mipharm Spa, an Italian leading Contract Manufacturing Organization (“CMO”) engaged in the manufacturing and packaging of a wide range of Finished Dosage Formulations (“FDFs”). The Group also provides product development services and clinical studies based on customer requirements and/or in house R&D.
MCP II total initial investment amounts to € 16.4 million, with the goal to increase the total investment with acquisitions of selected targets. Cassiopea Partners (Buyer’s financial advisor), Euteam (company owned by Mr. Maurizio Silvestri - ex CEO of Euticals) and some of Mipharm’s Managers invested alongside MCP II.
Current CEO Mr. Pierangelo Costa will continue to manage the company. Mipharm has posted sales of around € 37.9 m in 2015, with approx. 45 clients (Big Pharma, Global Generic companies, other pharmaceutical companies) located in 30 countries (i.e. in 2015 Exports account for about 65% of Revenues).
The investment is aimed at supporting international growth of the Company, leveraging on MCP II’s network and business development channels in the European and Asian markets.
Cassiopea Partners and the lawyersof R&P Legal of Milan acted respectively as financial and legal advisor for MCP II; Banca Popolare di Milano (BPM) and Banca Popolare Emilia Romagna (BPER) acted as financing banks providing the acquisition and M&A lines. The seller was supported by Rothschild as financial advisor and by the lawyersof Bonelli Erede Pappalardo as legal advisor.
The due diligence process was conducted by Ernst & Young (financial and tax areas), R&P Legal (legal area), Goetz Partners (business) and Tauw (Environmental).

The goal is to support the international growth of the Group through Mandarin’s Asian and European networking channels

Milan, 10th March 2016 – Mandarin Capital Partners II (MCP II)  has acquired a minority stake in the share capital of Marval Srl, an Italian company engaged in the mechanical machining of powertrain (cylinder heads and blocks, gear parts, etc.) and chassis components (brakes, suspension parts) for mid-power utility tractors, light construction vehicles such as mini-excavators, loaders and lift trucks, commercial vehicles (light vans, box trucks, etc.), luxury sport cars.
MCP II invested a total of € 12 m with a mix of capital increase and purchase of shares from the founders, and committed to injecting additional € 6 m in case of further needs for business development.
Current owner and CEO Mr. Nicola Marchiando will continue to manage the company. Marval has posted sales of around € 50 m in 2015, of which more than half through its Chinese subsidiary, ChangSha XiMai Mechanical Construction Co.
The investment is aimed at supporting international growth of the Group, leveraging on MCP II’s network and business development channels in the European and Asian markets.
The due diligence process was conducted by Ernst & Young (financial and tax areas), R&P Legal (legal area) and Roland Berger (business).
Mandarin CP